Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

580
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
580
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

710
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
710
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

580
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
580
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

498
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
498
Actuarial Approach01:20

Actuarial Approach

385
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
385

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling device.

Microbiology spectrum·2026
Same author

MultiSuSiE improves multi-ancestry fine-mapping in All of Us whole-genome sequencing data.

Nature genetics·2026
Same author

MultiSuSiE improves multi-ancestry fine-mapping in All of Us whole-genome sequencing data.

medRxiv : the preprint server for health sciences·2024
Same author

Pervasive correlations between causal disease effects of proximal SNPs vary with functional annotations and implicate stabilizing selection.

Research square·2024
Same author

Pervasive correlations between causal disease effects of proximal SNPs vary with functional annotations and implicate stabilizing selection.

medRxiv : the preprint server for health sciences·2023
Same author

Improving fine-mapping by modeling infinitesimal effects.

Nature genetics·2023
Same journal

Efficient evidence-based genome annotation with EviAnn.

Nature methods·2026
Same journal

ClairS: a deep-learning method for long-read tumor-normal pair somatic small variant calling.

Nature methods·2026
Same journal

RNAbpFlow: base pair-augmented SE(3) flow matching for conditional RNA 3D structure generation.

Nature methods·2026
Same journal

Spatio-DARLIN enables robust and efficient in situ lineage tracing in mice at single-cell resolution.

Nature methods·2026
Same journal

EasyGrid: a versatile platform for automated cryo-EM sample preparation and quality control.

Nature methods·2026
Same journal

Cloud-based microscope enables live neuroimaging for 24 h and beyond with worldwide access.

Nature methods·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Accurate liability estimation improves power in ascertained case-control studies.

Omer Weissbrod1, Christoph Lippert2, Dan Geiger1

  • 1Computer Science Department, Technion - Israel Institute of Technology, Haifa, Israel.

Nature Methods
|February 10, 2015
PubMed
Summary
This summary is machine-generated.

Linear mixed models (LMMs) struggle with large case-control studies. A new method, LEAP (liability estimator as a phenotype), improves power by using estimated phenotype severity for genome-wide association studies.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity
07:28

Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity

Published on: January 21, 2017

7.4K

Related Experiment Videos

Last Updated: Apr 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity
07:28

Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity

Published on: January 21, 2017

7.4K

Area of Science:

  • Genetics
  • Statistical Genetics
  • Bioinformatics

Background:

  • Linear mixed models (LMMs) are standard for genome-wide association studies (GWAS).
  • LMM performance degrades in large, nonrandomly ascertained case-control studies.
  • Existing methods face challenges with sample size inflation in GWAS.

Purpose of the Study:

  • To introduce a novel framework, LEAP (liability estimator as a phenotype), for GWAS.
  • To enhance statistical power in genome-wide association studies, particularly for case-control designs.
  • To address the performance limitations of LMMs with increasing sample sizes.

Main Methods:

  • Developed the LEAP framework, treating estimated liability as a phenotype.
  • Implemented a method to test for association using these estimated latent values.
  • Utilized simulation and real data to evaluate LEAP's performance.

Main Results:

  • LEAP demonstrates substantial power increases in genome-wide association studies.
  • The framework effectively handles nonrandom ascertainment in case-control studies.
  • LEAP shows improved performance compared to traditional LMMs with larger sample sizes.

Conclusions:

  • LEAP offers a powerful alternative for genome-wide association studies.
  • The liability estimator as a phenotype approach improves power in complex genetic studies.
  • LEAP provides a robust framework for analyzing large-scale case-control genetic data.